These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4029032)

  • 21. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy, tolerance and pharmacokinetics of temocillin in patients with respiratory tract infections.
    Legge JS; Reid TM; Palmer JB
    Drugs; 1985; 29 Suppl 5():118-21. PubMed ID: 4029014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temocillin in peripheral lymph.
    Bergan T; Engeset A; Olszewski W
    J Antimicrob Chemother; 1983 Jul; 12(1):59-63. PubMed ID: 6619047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temocillin concentrations in human tissues.
    Gould JG; Meikle G; Cooper DL; Horton R
    Drugs; 1985; 29 Suppl 5():167-70. PubMed ID: 3928320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].
    Wirth K; Schomerus M; Hengstmann JH
    Infection; 1976; 4(2):25-30. PubMed ID: 977133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients.
    Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ticarcillin in man.
    Davies BE; Humphrey MJ; Langley PF; Lees L; Legg B; Wadds GA
    Eur J Clin Pharmacol; 1982; 23(2):167-72. PubMed ID: 7140806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of piperacillin in subjects with various degrees of renal function.
    Welling PG; Craig WA; Bundtzen RW; Kwok FW; Gerber AU; Madsen PO
    Antimicrob Agents Chemother; 1983 Jun; 23(6):881-7. PubMed ID: 6225390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of the new broad spectrum penicillin CP-33994-2.
    Bergan T; Brodwall EK; Orjavik O
    Arzneimittelforschung; 1980; 30(7):1144-7. PubMed ID: 7191297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
    Prescott LF; Freestone S; McAuslane JA
    Br J Clin Pharmacol; 1993 Jan; 35(1):20-9. PubMed ID: 8448064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperacillin kinetics.
    Batra VK; Morrison JA; Lasseter KC; Joy VA
    Clin Pharmacol Ther; 1979 Jul; 26(1):41-53. PubMed ID: 445961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human pharmacokinetics of temocillin (BRL 17421) side chain epimers.
    Guest EA; Horton R; Mellows G; Slocombe B; Swaisland AJ; Tasker TC
    J Antimicrob Chemother; 1985 Mar; 15(3):327-36. PubMed ID: 3997707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic results and tissue concentrations of temocillin in surgical patients.
    Wittke RR; Adam D; Klein HE
    Drugs; 1985; 29 Suppl 5():221-6. PubMed ID: 4029028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.